Skip to content
CEpartner4U
  • Welcome
  • About us
    • Team
    • Jobs
  • Services
    • AR/EC Rep
    • Regulatory affairs
    • Quality system
    • CE/QMS Entry Packages©
    • Clinical evaluation
    • Training
  • UKCApartner4U
  • Information
    • F.A.Q. AR/EC Rep
    • Links
  • Library
  • News
  • Network
  • Contact

About:m.vandervoort

Posts by m.vandervoort :

  • European Commission issued a Q&A on Gradual Roll-out of EUDAMED, 21 November 2024 in Uncategorized
  • European Commission issues Q&A on Article 10a of the MDR/IVDR, 30 October 2024 in Uncategorized
  • MDCG 2022-5 Rev. 1 published on (MDR) borderline products: medical devices and medicinal products, 29 October 2024 in Uncategorized
  • MDCG issued 2024-13 on regulatory status of EtO, 29 October 2024 in Uncategorized
  • MDCG 2021-25 Rev.1 report issued on transitional provisions, 16 October 2024 in Uncategorized
  • Current status MDR / IVDR Notified Bodies, 9 October 2024 in Uncategorized
  • Call to medical device manufacturers: implement an effective PMS system, 8 October 2024 in Uncategorized
  • MDCG issued 2024-11 on qualification of in vitro diagnostic medical devices, 8 October 2024 in Uncategorized
  • MDCG 2021-4 Q&A on how to handle class D IVDs during transition to IVDR – revision 1, 25 September 2024 in Uncategorized
  • Revision 2 of MDR and IVDR language requirements for manufacturers published, 13 September 2024 in Uncategorized
  • «
  • 1
  • 2
  • 3
  • 4
  • …
  • 12
  • »

Stay informed

Please check your inbox or spam box to confirm

Copyright 2026 CEpartner4U | Esdoornlaan 13 | 3951 DB Maarn | The Netherlands | +31.6.516.536.26 | office@cepartner4u.com
  • enEnglish